Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.8/5
3SBio Inc

3SBio Inc (1530 HK)

131
Analysis
Health CareChina
3SBio, Inc. is a biotechnology company located in China. The Company focuses on mammalian cell-based biopharmaceuticals in the biotechnology industry. 3SBio also develops, manufactures and markets biopharmaceutical products globally.
more
05 Jan 2021 01:51

Pre-IPO Bio-Thera Solutions - Insights on Pipeline and the Competitive Landscape

This article summarized the insights on major products of Bio-Thera Solutions in the pipeline and related competitive landscape with other key...

Logo
430 Views
Share
18 Dec 2020 12:56

China Healthcare: Macro Themes

This Insight summarizes the takeaways from a recent China healthcare industry conference.  There is much talk of pressures on the industry, but...

Share
02 Dec 2020 01:36

Harbour Biomed IPO: Positive Thoughts in Brief

This Insight includes a brief analysis of Harbour Biomed and its proposed listing on the HKEX. We like the deal at the price range offered.

Share
14 Oct 2020 08:08

Simcere Pharmaceutical IPO: Valuation Insights

We think that an attractive PEG valuation and solid cornerstone support makes Simcere tempting at the proposed pricing range

Logo
524 Views
Share
29 Jun 2020 08:29

Asia Short Interest Weekly - Big Jump in Japan Shorts

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
374 Views
Share
x